Osiris’ Race to Market an FDA-Approved Stem Cell Product

Osiris’ Race to Market an FDA-Approved Stem Cell Product

While human embryonic stem cells have gotten the lion’s share of attention from the popular press and the public, companies developing stem cell therapies from other sources are advancing these products rapidly and reaping milestone payments from partnerships. Closest to an off the shelf stem cell product is Osiris Therapeutics’ Prochymal, a human mesenchymal stem cell (MSC) therapy.

Mesenchymal stem cells are found in human bone marrow, not human embryos. If this works out we may have a viable stem cell treatment in a several years. Next stop, gene therapy.